AstraZeneca resumes COVID-19 vaccine trial after U.K. green light

AstraZeneca resumes COVID-19 vaccine trial after U.K. green light

Hindu

Published

AstraZeneca announced on Wednesday it had “voluntarily paused” its trial of the vaccine developed alongside Oxford University after the volunteer developed an unexplained illness

Full Article